Showing results (51-60 of 330) with videos related to
Sort By:
Pageof 33
European Heart Journal|April 1, 2015
Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery diseaseStephanie Ross, Hertzel C Gerstein, John Eikelboom, et al.Diabetes, Obesity & Metabolism|July 3, 2026
A Highly Powered Large Outcomes Randomised Controlled Trial Will Usually, but Not Always, Have Balanced Groups at BaselineHertzel C Gerstein, Zayeeda Labiba, Sibylle Hess, et al.Diabetes, Obesity & Metabolism|February 21, 2019
Effects of basal insulin glargine and omega-3 on lower limb arterial disease outcome in patients with dysglycaemia: An analysis of the Outcome Reduction with an Initial Glargine INtervention (ORIGIN) trialGilles R Dagenais, Hyejung Jung, Peter Bogaty, et al.Diabetes Care|January 30, 2007
A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulinAzim S Gangji, Tali Cukierman, Hertzel C Gerstein, et al.Endocrine|October 2, 2007
Transgenerational effects of fetal and neonatal exposure to nicotineAlison C Holloway, Donald Q Cuu, Katherine M Morrison, et al.BMC Medical Informatics and Decision Making|July 10, 2012
Impact of a computerized system for evidence-based diabetes care on completeness of records: a before-after studyPavel S Roshanov, Hertzel C Gerstein, Dereck L Hunt, et al.Diabetes Care|January 14, 2021
HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regressionM Angelyn Bethel, Rafael Diaz, Noelia Castellana, et al.Journal of Alzheimer'S Disease : JAD|April 18, 2022
Biomarkers of Prevalent and Incident Cognitive Dysfunction in People with Dysglycemia: Data from the ORIGIN TrialTali Cukierman-Yaffe, Shun-Fu Lee, Guillaume Pare, et al.Diabetes, Obesity & Metabolism|January 13, 2026
Prediction of heart failure as the first major cardiovascular disease event in type 2 diabetesJulian W Sacre, Kristin Lundegard, Kamel Mohammedi, et al.Elife|October 16, 2020
Effects of lifelong testosterone exposure on health and disease using Mendelian randomizationPedrum Mohammadi-Shemirani, Michael Chong, Marie Pigeyre, et al.Pageof 33